Industry-University Collaboration system with world class universities

HYUNDAI BIOSCIENCE’s research efforts continue to exquisitely improve the worldwide source technology of organic-inorganic hybrid technology, and at the same time apply it to commercialization. In order to go more deeply and widely into R&D, HYUNDAI BIOSCIENCE has built Industry-University collaboration systems with world-class universities, and has shared human and physical resources to elevate the level of organic-inorganic hybrid technology.

HYUNDAI BIOSCIENCE has started early in building industry-university collaborations with Ewha Women’s University ( in order to hold collaborative research with Ewha Women’s University Chair Professor Jin-ho Choi, founder of CNPharm (major shareholder of HYUNDAI BIOSCIENCE). It has continued collaborative research under close relations with the research team (Chemistry/Nanoscience) of Chair Professor Jin-ho Choi. In order to strengthen efficient cooperation with Ewha Women’s University and Professor Jin-ho Choi’s research team, HYUNDAI BIOSCIENCE has moved its office last August 2008 to Ewha University’s Industry-University Collaboration Building.

HYUNDAI BIOSCIENCE is performing a project to develop a “nanomedicine DDS that prevents side effects after cataract surgery” together with Seoul National University ( , Hanyang University ( and so on. This project, supervised by HYUNDAI BIOSCIENCE, was selected as a national project by the Korea Evaluation Institute of Industrial Technology (KEIT), under the Ministry of Trade, Industry and Energy (MOTIE) and was supported with a total of 3 Billion KRW for research funds. HYUNDAI BIOSCIENCE, together with the two universities and Seoul National University Hospital ( is scheduled to develop an instillation nanomedicine DDS until 2019. It is expected that this super-generic instillation to be created will have greatly reduced amount of steroids used, since existing antibiotics and anti-infection instillations use steroids with serious side effects. At the same time, the medical effects of a single use of this instillation is expected to last for 1 week.

HYUNDAI BIOSCIENCE asked the team of Professor Tae-yoon Kim of Catholic University of Korea (, Sung-mo Hospital, Dermatology about the effects on the infection and skin damage when Vitabrid CG, the source material of Vitabrid C12, is applied to skin infected with atopy and psoriasis. Results showed that it has outstanding effects on anti-infection and restoration of skin cells. Professor Tae-yoon Kim is planning to publish these research results on academic journals of the same level with SCI.

HYUNDAI BIOSCIENCE is currently working on various efficacy-based experiments and basic clinical experiments together with Hoseo University Toxicological Research Center (, a GLP institution verified by the Ministry of Food and Drug Safety. Specifically, it was a great topic of conversation as it gained results when Vitabrid CG (the source material of Vitabrid C12) applied to skin showed effects on hair growth promotion almost 1 week faster compared to a globally famous hair growth solution.